206 related articles for article (PubMed ID: 23041142)
1. Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.
Dimmock NJ; Dove BK; Meng B; Scott PD; Taylor I; Cheung L; Hallis B; Marriott AC; Carroll MW; Easton AJ
Antiviral Res; 2012 Dec; 96(3):376-85. PubMed ID: 23041142
[TBL] [Abstract][Full Text] [Related]
2. Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established.
Dimmock NJ; Dove BK; Scott PD; Meng B; Taylor I; Cheung L; Hallis B; Marriott AC; Carroll MW; Easton AJ
PLoS One; 2012; 7(12):e49394. PubMed ID: 23251341
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
[TBL] [Abstract][Full Text] [Related]
4. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.
Hurt AC; Holien JK; Parker M; Kelso A; Barr IG
J Virol; 2009 Oct; 83(20):10366-73. PubMed ID: 19641000
[TBL] [Abstract][Full Text] [Related]
5. A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral.
Smith CM; Scott PD; O'Callaghan C; Easton AJ; Dimmock NJ
Viruses; 2016 Aug; 8(8):. PubMed ID: 27556481
[TBL] [Abstract][Full Text] [Related]
6. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
Kiso M; Shinya K; Shimojima M; Takano R; Takahashi K; Katsura H; Kakugawa S; Le MT; Yamashita M; Furuta Y; Ozawa M; Kawaoka Y
PLoS Pathog; 2010 Aug; 6(8):e1001079. PubMed ID: 20865125
[TBL] [Abstract][Full Text] [Related]
7. Competitive transmissibility and fitness of oseltamivirsensitive and resistant pandemic influenza H1N1 viruses in ferrets.
Duan S; Boltz DA; Seiler P; Li J; Bragstad K; Nielsen LP; Webby RJ; Webster RG; Govorkova EA
Influenza Other Respir Viruses; 2011 May; 5(Suppl 1):79-82. PubMed ID: 21751461
[No Abstract] [Full Text] [Related]
8. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
[TBL] [Abstract][Full Text] [Related]
9. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.
Seibert CW; Kaminski M; Philipp J; Rubbenstroth D; Albrecht RA; Schwalm F; Stertz S; Medina RA; Kochs G; García-Sastre A; Staeheli P; Palese P
J Virol; 2010 Nov; 84(21):11219-26. PubMed ID: 20739532
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets.
Duan S; Boltz DA; Seiler P; Li J; Bragstad K; Nielsen LP; Webby RJ; Webster RG; Govorkova EA
PLoS Pathog; 2010 Jul; 6(7):e1001022. PubMed ID: 20686654
[TBL] [Abstract][Full Text] [Related]
11. Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity.
Vidaña B; Martínez-Orellana P; Martorell JM; Baratelli M; Martínez J; Migura-Garcia L; Córdoba L; Pérez M; Casas I; Pozo F; Fraile L; Majó N; Montoya M
Viruses; 2020 Jul; 12(8):. PubMed ID: 32721992
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
[TBL] [Abstract][Full Text] [Related]
13. Mammalian pathogenesis of oseltamivir-resistant pandemic (H1N1) 2009 influenza virus isolated in South Korea.
Kwon D; Shin K; Kim SJ; Lee JY; Kang C
Virus Res; 2014 Jun; 185():41-6. PubMed ID: 24657788
[TBL] [Abstract][Full Text] [Related]
14. Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.
Marriott AC; Dove BK; Whittaker CJ; Bruce C; Ryan KA; Bean TJ; Rayner E; Pearson G; Taylor I; Dowall S; Plank J; Newman E; Barclay WS; Dimmock NJ; Easton AJ; Hallis B; Silman NJ; Carroll MW
PLoS One; 2014; 9(4):e94090. PubMed ID: 24709834
[TBL] [Abstract][Full Text] [Related]
15. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
[TBL] [Abstract][Full Text] [Related]
16. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
Hurt AC; Lowther S; Middleton D; Barr IG
Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice.
Takahashi E; Sawabuchi T; Kimoto T; Sakai S; Kido H
J Dairy Sci; 2019 Nov; 102(11):9559-9569. PubMed ID: 31495632
[TBL] [Abstract][Full Text] [Related]
18. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
Duhaut SD; Dimmock NJ
Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
[TBL] [Abstract][Full Text] [Related]
19. The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.
Paules CI; Lakdawala S; McAuliffe JM; Paskel M; Vogel L; Kallewaard NL; Zhu Q; Subbarao K
J Infect Dis; 2017 Aug; 216(3):356-365. PubMed ID: 28633457
[TBL] [Abstract][Full Text] [Related]
20. Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
Tilmanis D; Koszalka P; Barr IG; Rossignol JF; Mifsud E; Hurt AC
Antiviral Res; 2020 Aug; 180():104851. PubMed ID: 32544408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
